Search Results - "PILEWSKI, Joseph"

Refine Results
  1. 1

    Update on Lung Transplantation for Cystic Fibrosis by Pilewski, Joseph M.

    Published in Clinics in chest medicine (01-12-2022)
    “…Lung transplantation provides a treatment option for many individuals with advanced lung disease due to cystic fibrosis (CF). Since the first transplants for…”
    Get full text
    Journal Article
  2. 2

    CFTR Modulators to the Rescue of Individuals with Cystic Fibrosis and Advanced Lung Disease by Myerburg, Mike, Pilewski, Joseph M.

    “…The development of CFTR modulators has been one of the most remarkable stories in respiratory medicine. Defining the genetic, molecular, and cellular biology…”
    Get full text
    Journal Article
  3. 3

    Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR by Donaldson, Scott H, Pilewski, Joseph M, Griese, Matthias, Cooke, Jon, Viswanathan, Lakshmi, Tullis, Elizabeth, Davies, Jane C, Lekstrom-Himes, Julie A, Wang, Linda T

    “…Tezacaftor (formerly VX-661) is an investigational small molecule that improves processing and trafficking of the cystic fibrosis transmembrane conductance…”
    Get full text
    Journal Article
  4. 4

    Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions by Garrett, Sara M, Hsu, Eileen, Thomas, Justin M, Pilewski, Joseph M, Feghali-Bostwick, Carol

    Published in PloS one (25-11-2019)
    “…Type 2 insulin-like growth factor (IGF-II) levels are increased in fibrosing lung diseases such as idiopathic pulmonary fibrosis (IPF) and scleroderma/systemic…”
    Get full text
    Journal Article
  5. 5

    Acidic Microenvironment Determines Antibiotic Susceptibility and Biofilm Formation of Pseudomonas aeruginosa by Lin, Qiao, Pilewski, Joseph M., Di, Y. Peter

    Published in Frontiers in microbiology (19-11-2021)
    “…Pseudomonas aeruginosa is the most prevalent bacterial species that contribute to cystic fibrosis (CF) respiratory failure. The impaired function of CF…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease by Chen, Zhi-Hua, Kim, Hong Pyo, Sciurba, Frank C, Lee, Seon-Jin, Feghali-Bostwick, Carol, Stolz, Donna B, Dhir, Rajiv, Landreneau, Rodney J, Schuchert, Mathew J, Yousem, Samuel A, Nakahira, Kiichi, Pilewski, Joseph M, Lee, Janet S, Zhang, Yingze, Ryter, Stefan W, Choi, Augustine M K

    Published in PloS one (02-10-2008)
    “…Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by abnormal cellular responses to cigarette smoke, resulting in tissue…”
    Get full text
    Journal Article
  8. 8

    Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation by Toyoda, Yoshiya, MD, PhD, Bhama, Jay K., MD, Shigemura, Norihisa, MD, Zaldonis, Diana, MPH, BSN, Pilewski, Joseph, MD, Crespo, Maria, MD, Bermudez, Christian, MD

    “…Background Preoperative extracorporeal membrane oxygenation (ECMO) is a risk factor for poor outcome and currently considered a contraindication to lung…”
    Get full text
    Journal Article
  9. 9

    Palliative Care and Location of Death in Decedents With Idiopathic Pulmonary Fibrosis by Lindell, Kathleen O., PhD, RN, Liang, Zhan, MSN, RN, Hoffman, Leslie A., PhD, RN, Rosenzweig, Margaret Q., PhD, FNP-BC, AOCNP, Saul, Melissa I., MS, Pilewski, Joseph M., MD, Gibson, Kevin F., MD, Kaminski, Naftali, MD

    Published in Chest (01-02-2015)
    “…BACKGROUND Palliative care, integrated early, may reduce symptom burden in patients with idiopathic pulmonary fibrosis (IPF). However, limited information…”
    Get full text
    Journal Article
  10. 10

    First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry by Renaud, Ludivine, Waldrep, Kristy M, da Silveira, Willian A, Pilewski, Joseph M, Feghali-Bostwick, Carol A

    “…Systemic sclerosis (SSc) is a connective tissue disorder that results in fibrosis of the skin and visceral organs. SSc-associated pulmonary fibrosis (SSc-PF)…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines by Ramos, Kathleen J., Smith, Patrick J., McKone, Edward F., Pilewski, Joseph M., Lucy, Amy, Hempstead, Sarah E., Tallarico, Erin, Faro, Albert, Rosenbluth, Daniel B., Gray, Alice L., Dunitz, Jordan M.

    Published in Journal of cystic fibrosis (01-05-2019)
    “…Provide recommendations to the cystic fibrosis (CF) community to facilitate timely referral for lung transplantation for individuals with CF. The CF Foundation…”
    Get full text
    Journal Article
  13. 13

    Reduced Cathepsin L expression and secretion into the extracellular milieu contribute to lung fibrosis in systemic sclerosis by Mouawad, Joe E, Sharma, Shailza, Renaud, Ludivine, Pilewski, Joseph M, Nadig, Satish N, Feghali-Bostwick, Carol

    Published in Rheumatology (Oxford, England) (01-03-2023)
    “…Abstract Objectives Lung fibrosis is the leading cause of death in SSc, with no cure currently available. Antifibrotic Endostatin (ES) production does not…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Call for Changes in Lung Allocation to Reduce Transplant Wait-List Mortality for Cystic Fibrosis by Nolley, Eric P, Pilewski, Joseph M

    “…Nolley and Pilewaski discuss a study that determines ways to effectively change in lung allocation to reduce transplant wait-list mortality for cystic…”
    Get full text
    Journal Article
  16. 16

    Challenges in the use of highly effective modulator treatment for cystic fibrosis by Ramos, Kathleen J., Pilewski, Joseph M., Taylor-Cousar, Jennifer L.

    Published in Journal of cystic fibrosis (01-05-2021)
    “…•Highly effective modulator treatment (HEMT) may be indicated in complex settings.•People with native CF lung disease are likely to benefit from initiation of…”
    Get full text
    Journal Article
  17. 17

    Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis by Stapleton, Amanda L., Kimple, Adam J., Goralski, Jennifer L., Nouraie, S. Mehdi, Branstetter, Barton F, Shaffer, Amber D, Pilewski, Joseph M, Senior, Brent A, Lee, Stella E, Zemke, Anna C.

    Published in Journal of cystic fibrosis (01-09-2022)
    “…•HEMT improves symptoms of chronic rhinosinusitis within a week.•Improvement of symptoms lasts out to at least 6 months.•HEMT improves sinus opacification on…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Role of Extracellular Vesicles in the Propagation of Lung Fibrosis in Systemic Sclerosis by Mouawad, Joe E., Sanderson, Matthew, Sharma, Shailza, Helke, Kristi L., Pilewski, Joseph M., Nadig, Satish N., Feghali‐Bostwick, Carol

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2023)
    “…Objectives Systemic sclerosis (SSc) has the highest mortality rate among the rheumatic diseases, with lung fibrosis leading as the cause of death. A…”
    Get full text
    Journal Article
  20. 20

    AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality by Zhang, Hongbo, Luo, Jiadi, Alcorn, John F, Chen, Kong, Fan, Songqing, Pilewski, Joseph, Liu, Aizhong, Chen, Wei, Kolls, Jay K, Wang, Jieru

    Published in The Journal of immunology (1950) (01-06-2017)
    “…The absent in melanoma 2 (AIM2) inflammasome plays an important role in many viral and bacterial infections, but very little is known about its role in RNA…”
    Get full text
    Journal Article